Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
GLI family zinc finger 3 | 8 | 0 | 0 | 8 |
AR protein | 13 | 0 | 0 | 13 |
aldehyde dehydrogenase 1 family, member A1 | 8 | 0 | 0 | 8 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 6 | 0 | 0 | 6 |
estrogen nuclear receptor alpha | 11 | 0 | 0 | 11 |
peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 7 | 0 | 0 | 7 |
activating transcription factor 6 | 6 | 0 | 0 | 6 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
Histone H2A.x | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
heat shock protein beta-1 | 6 | 0 | 0 | 6 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
Glutamate receptor 2 | 4 | 0 | 0 | 4 |
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
Chain A, 2-oxoglutarate Oxygenase | 7 | 0 | 0 | 7 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
Chain A, Cruzipain | 3 | 0 | 0 | 3 |
15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
USP1 protein, partial | 6 | 0 | 0 | 6 |
TDP1 protein | 10 | 0 | 0 | 10 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 11 | 0 | 0 | 11 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
Bloom syndrome protein isoform 1 | 8 | 0 | 0 | 8 |
cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
histone acetyltransferase KAT2A isoform 1 | 8 | 0 | 0 | 8 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 6 | 1 | 0 | 7 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 2 |
Trypsin | 0 | 2 | 0 | 3 |
Coagulation factor VII | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Aromatase | 0 | 2 | 0 | 2 |
Tissue factor | 0 | 2 | 0 | 2 |
Fatty acid-binding protein, adipocyte | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit delta | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 1 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 1 | 0 | 7 |
Prostaglandin G/H synthase 2 | 0 | 0 | 1 | 2 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 2 | 2 |
Histamine H2 receptor | 3 | 0 | 0 | 3 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Calmodulin | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 1 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 1 | 1 | 8 |
Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Fatty acid-binding protein 5 | 0 | 2 | 0 | 2 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
GABA theta subunit | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit epsilon | 6 | 1 | 0 | 7 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
thioredoxin reductase | 8 | 0 | 0 | 8 |
ATAD5 protein, partial | 3 | 0 | 0 | 3 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
67.9K protein | 3 | 0 | 0 | 3 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
ATP-binding cassette sub-family C member 3 | 0 | 7 | 0 | 7 |
Multidrug resistance-associated protein 4 | 0 | 7 | 0 | 7 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 9 | 0 | 9 |
Canalicular multispecific organic anion transporter 1 | 0 | 7 | 0 | 7 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 3 |
Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 3 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 3 |
NPYLR7B | 0 | 0 | 1 | 1 |
peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
Coagulation factor XII | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 5 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 5 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 5 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 5 |
Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 5 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 5 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 5 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
Luciferase | 5 | 0 | 0 | 5 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
GLS protein | 2 | 0 | 0 | 2 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
EWS/FLI fusion protein | 6 | 0 | 0 | 6 |
glucocorticoid receptor [Homo sapiens] | 9 | 0 | 0 | 9 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
arylsulfatase A | 5 | 0 | 0 | 5 |
pyruvate kinase | 2 | 0 | 0 | 2 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 4 | 0 | 0 | 4 |
snurportin-1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
geminin | 7 | 0 | 0 | 7 |
M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
Polyphenol oxidase 2 | 0 | 0 | 0 | 2 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Plasma kallikrein | 0 | 0 | 0 | 2 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 3 |
Adenosine receptor A2a | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
SLC16A10 protein | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 2 |
Carbonic anhydrase 15 | 0 | 0 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 2 | 0 | 2 |
CAAX prenyl protease 2 isoform 2 | 0 | 0 | 0 | 1 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
streptokinase A precursor | 0 | 0 | 2 | 2 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Tubulin beta-4A chain | 0 | 1 | 0 | 1 |
Tubulin beta chain | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 2 |
Tubulin alpha-3C chain | 0 | 1 | 0 | 1 |
Spike glycoprotein | 4 | 1 | 0 | 5 |
Tubulin alpha-1B chain | 0 | 1 | 0 | 1 |
Tubulin alpha-4A chain | 0 | 1 | 0 | 1 |
Tubulin beta-4B chain | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
DNA gyrase subunit A | 0 | 2 | 0 | 3 |
DNA primase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 7 | 0 | 8 |
Tubulin beta-3 chain | 0 | 1 | 0 | 1 |
Tubulin beta-2A chain | 0 | 1 | 0 | 1 |
Tubulin beta-8 chain | 0 | 1 | 0 | 1 |
Tubulin alpha-3E chain | 0 | 1 | 0 | 1 |
Tubulin alpha-1A chain | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Tubulin alpha-1C chain | 0 | 1 | 0 | 1 |
Tubulin beta-6 chain | 0 | 1 | 0 | 1 |
Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
Tubulin beta-1 chain | 0 | 1 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
estrogen receptor 2 (ER beta) | 5 | 0 | 0 | 5 |
progesterone receptor | 4 | 0 | 0 | 4 |
estrogen-related nuclear receptor alpha | 6 | 0 | 0 | 6 |
farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
pregnane X nuclear receptor | 5 | 0 | 0 | 5 |
peroxisome proliferator activated receptor gamma | 8 | 0 | 0 | 8 |
caspase-3 | 2 | 0 | 0 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 7 | 0 | 0 | 7 |
Free fatty acid receptor 1 | 0 | 0 | 1 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 7 | 0 | 0 | 7 |
Fatty acid-binding protein, heart | 0 | 2 | 0 | 2 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 7 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
Free fatty acid receptor 4 | 0 | 0 | 1 | 1 |
retinoic acid receptor alpha isoform 1 | 0 | 1 | 0 | 1 |
retinoic acid receptor RXR-alpha isoform a | 0 | 1 | 0 | 1 |
lethal factor (plasmid) | 3 | 0 | 0 | 3 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
endonuclease IV | 2 | 0 | 0 | 2 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
Fumarate hydratase | 2 | 0 | 0 | 2 |
GALC protein | 3 | 0 | 0 | 3 |
TSHR protein | 1 | 0 | 0 | 1 |
Thrombopoietin | 2 | 0 | 0 | 2 |
PINK1 | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
G | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
polyprotein | 2 | 0 | 0 | 2 |
Parkin | 2 | 0 | 0 | 2 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
IDH1 | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
Spike glycoprotein | 0 | 1 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
Aurora kinase A | 0 | 1 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 1 | 0 | 1 |
3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase JAK2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 1 |
Interferon beta | 3 | 0 | 0 | 3 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Integrin beta-3 | 2 | 0 | 0 | 2 |
Procathepsin L | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 2 | 0 | 0 | 2 |
Ornithine decarboxylase | 1 | 0 | 0 | 2 |
Platelet-derived growth factor receptor beta | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Mast/stem cell growth factor receptor Kit | 0 | 1 | 0 | 1 |
Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
Alpha-synuclein | 1 | 1 | 0 | 2 |
Signal transducer and activator of transcription 3 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 8 | 0 | 1 | 0 | 1 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Angiopoietin-1 receptor | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Anoctamin-1 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
Ataxin-2 | 4 | 0 | 0 | 4 |
Angiotensin-converting enzyme 2 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
STE24 | 0 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
XBP1 | 0 | 1 | 0 | 1 |
Caspase-7 | 3 | 0 | 0 | 3 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
caspase-3 | 3 | 0 | 0 | 3 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
DNA damage-inducible transcript 3 protein | 0 | 1 | 0 | 1 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 0 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
Ubiquitin carboxyl-terminal hydrolase 1 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 1 | 1 | 2 |
D(2) dopamine receptor | 0 | 1 | 1 | 2 |
D | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
WD repeat-containing protein 48 | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 0 | 1 | 1 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
Cytochrome P450 2D6 | 0 | 0 | 1 | 1 |
Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
Cytochrome P450 2C9 | 0 | 0 | 1 | 1 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 0 | 1 | 1 |
Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
Nuclear receptor ROR-gamma | 0 | 1 | 1 | 2 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
Tubulin--tyrosine ligase | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |